Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daisuke Honda

6PUBLICATIONS
9CO-AUTHORS
Catalysis and mechanisms of reactionsMolecular medicineToxicology (incl. clinical toxicology)Clinical pharmacology and therapeuticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Feb 22, 2026
Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism.

Fumihiko Koiwa, Daisuke Honda, Seigo Akari

|Dec 04, 2023
Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study.

Daijo Inaguma, Fumihiko Koiwa, Masanori Tokumoto

|Sep 11, 2023
Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Randomized Placebo-Controlled Trial.

Takashi Shigematsu, Fumihiko Koiwa, Yoshitaka Isaka

|Jun 28, 2022
First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties.

Junichiro James Kazama, Fumihiko Koiwa, Keitaro Yokoyama

|Mar 26, 2022
First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants.

Fumihiko Koiwa, Rie Yazawa, Masafumi Fukagawa

|Jan 27, 2018
Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study).

Takashi Wada, Tatsuo Hosoya, Daisuke Honda

Pageof 1

Frequent Collaborators

2 joint publications

Masafumi Fukagawa

2 joint publications

Tadao Akizawa

1 joint publications

Takashi Shigematsu

1 joint publications

Fumihiko Koiwa

1 joint publications

Yoshitaka Isaka

1 joint publications

Keiko Hagita

1 joint publications

Yukihisa S Watanabe

1 joint publications

Daijo Inaguma

1 joint publications

Shinji Yoneda

Frequent Collaborators

2 joint publications

Masafumi Fukagawa

2 joint publications

Tadao Akizawa

1 joint publications

Takashi Shigematsu

1 joint publications

Fumihiko Koiwa

Top Related Videos

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on : Jul 14, 2023

2.4K
See more related videos

Top Related Videos

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats <em>via</em> Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on : Jul 14, 2023

2.4K
See more related videos